HKUST and PhIRDA Sign MoU to Establish Innovation Centers
The Hong Kong University of Science and Technology (HKUST) and the China Pharmaceutical Innovation and...
Greater Bay Area
Shanghai Pharmaceuticals Partners with Baiyun District for Health Initiative
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has entered into a strategic cooperation agreement...
Sanofi’s Sarclisa Approved for Import in Shenzhen via Greater Bay Area Scheme
French pharmaceutical major Sanofi (NASDAQ: SNY) has announced import approval in Shenzhen via the Greater...
Guangdong Adds Hospitals to GBA Drug and Device Green Channel
The Health Commission of Guangdong Province (GDHC) has released a second list of designated medical...
Shenzhen United Family Hospital Partners with GBA Medical Delegation
Shenzhen United Family Hospital has struck a partnership with a medical delegation from the Guangdong-Hong...
Grand Pharma’s Jext Auto-Injector Approved for Import into Greater Bay Area
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced receiving official approval from the Guangdong...
Dartsbio Pharmaceuticals Secures RMB 100 Million in Series B Financing
Guangdong-based antibody drug developer Dartsbio Pharmaceuticals has reportedly raised over RMB 100 million in a...
Roche and HKSTP Collaborate to Boost Life Sciences in Greater Bay Area
Swiss pharmaceutical giant Roche (SWX: ROG) has signed a multi-faceted collaboration agreement with the Hong...
Shanghai Pharmaceuticals Partners with HKSTP for Biomedicine Cultivation Program
Shanghai Pharmaceuticals (HKG: 2607, SHA: 601607), Shanghai Biomedical Frontier Industry Innovation Center Co., Ltd, and...
Great Bay Bio Completes USD 15M Pre-Series B Financing to Advance AI Bioprocessing Platforms
Great Bay Bio (GBB), a Hong Kong-based biotechnology firm, announced the completion of a USD...
AWS Partners with Zhongshan to Launch Smart Manufacturing and Biomedical Digital Center
Amazon Web Services (AWS) and Zhongshan’s Bureau of Commerce announced a partnership at the China...
Novartis’ Aimovig Launches in China via GBA Early Access Scheme for Migraine Treatment
Swiss pharma giant Novartis’ (NYSE: NVS) migraine therapy Aimovig (erenumab) was administered for the first...
NMPA Releases Plans to Support HK and Macau Drug, Device Production in Mainland Cities
The National Medical Products Administration (NMPA) has released two implementation plans aimed at supporting Hong...
Boehringer Ingelheim Venture Fund and Hong Kong Science Park Launch Co-Incubation Plan
Germany-based pharmaceutical giant Boehringer Ingelheim’s venture fund (BIVF) and China-based Hong Kong Science & Technology...